Scientists are also studying whether the drugs could play a role in addressing lingering neurological symptoms reported after COVID-19 infection, including brain fog, fatigue and cognitive impairment
- The arGLP-1 s have demonstrated a CV benefit in patients with DM2 that appears to extend to patients with reduced renal function
Blood sugar can matter for some people GLP1 medications alone are unlikely to cause dangerously low blood sugar, but risk increases when they are combined with insulin or sulfonylureas
Immunity 51(3):508-521.e6 Rowley AH, Wylie KM, Kim KYA, Pink AJ, Yang A, Reindel R et al (2015) The transcriptional profile of coronary arteritis in Kawasaki disease
Right panel: n = 5, p = 0.5282
However, it is important to note that this study was very small and only looked at a sample of 11 people